Drug promotion materials (DPM) are commonly used by pharmaceutical companies to provide information to doctors about drugs. The information in DPM may have an impact on treatment even more than the biomedical quality of the drug [1] .
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In the drug promotion process, pharmaceutical companies make many claims about the efficacy, safety and 'quality' of the products. These claims should be clear, valid and justifiable. In scientific literature, each claim should be supported by evidence. Therefore, they are expected to provide evidence to support the claims made in DPM. The high quality references increase the authenti-city of the evidence. The aim of this study was to examine the quality of scientific supportive evidence used in DPM in Sri Lanka.
A group of physicians, paediatricians, and general practitioners were informed about the study through emails and requested to collect DPM. DPM received from these doctors were included in the study. Information presented in those DPM was extracted by two researchers working together. Another researcher checked and verified the extracted information.
We studied 211 DPM collected from August to October 2015. Two hundred and eight DPM out of 211 had one or more claims about 'quality' of the product. From 208 DPM which claimed about 'quality' of the product, only 167 (80.3%) provided evidence, as references, for the claim.
A total of 569 references were found in those 167 DPM. Five hundred and one were journal articles (88.0%). 497 were PubMed indexed (87.3%) journals and 453 (79.6%) were ISI indexed journals. This ISI indexed journals have an Impact Factor and a higher impact factor indicates a higher ranked journal. Ninety three journals (18%) had an impact factor of more than 10, 160 journals (32%) had an impact factor of more than 5 while 341
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Twenty references (3.5%) could not be traced using the given information in DPM. Twenty one were non-journal websites, 16 of these webpages (76%) were not available, directed to another database or were altered in such a way that it did not provide the expected information. The text size used for the reference list was divided into four categories. Compared to the citation text, 2.4% had same size text in reference list, 20.4% had half or more size list, 75.4% had less than half size text and 1.8% could not be read without a magnifying glass (or somebody with very good vision). The name and address of manu-facturer or distributor was mentioned in only 185 of DPM (87.6%).
Some DPM claims about 'quality' of the drug was not supported by evidence. Considerable number of DPM used poor quality scientific research as references. Some of these references could not be traced. This study empha-sises the importance of searching related scientific literature by user themselves before accepting claims in DPM.
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